HKSE - Delayed Quote HKD

Sisram Medical Ltd (1696.HK)

3.540 +0.260 (+7.93%)
At close: 4:08 PM GMT+8
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
351,597.000
354,480.000
294,294.000
162,095.000
Cost of Revenue
143,687.000
152,254.000
127,433.000
71,794.000
Gross Profit
207,910.000
202,226.000
166,861.000
90,301.000
Operating Expense
160,186.000
146,782.000
116,302.000
69,916.000
Operating Income
47,724.000
55,444.000
50,559.000
20,385.000
Net Non Operating Interest Income Expense
-1,360.000
-1,359.000
-1,462.000
-291.000
Pretax Income
41,902.000
44,242.000
41,672.000
16,662.000
Tax Provision
3,566.000
4,162.000
9,152.000
1,982.000
Net Income Common Stockholders
38,448.000
40,170.000
31,245.000
13,344.000
Diluted NI Available to Com Stockholders
38,448.000
40,170.000
31,245.000
13,344.000
Basic EPS
0.08
0.09
0.07
0.03
Diluted EPS
0.08
0.09
0.07
0.03
Basic Average Shares
466,814.442
466,245.938
452,544.641
442,155.600
Diluted Average Shares
468,016.539
466,774.332
452,867.614
442,155.600
Total Expenses
303,873.000
299,036.000
243,735.000
141,710.000
Net Income from Continuing & Discontinued Operation
38,448.000
40,170.000
31,245.000
13,344.000
Normalized Income
38,448.000
40,170.000
30,861.053
13,045.325
Interest Income
1,830.000
613.000
543.000
773.000
Interest Expense
1,973.000
1,972.000
2,005.000
1,064.000
Net Interest Income
-1,360.000
-1,359.000
-1,462.000
-291.000
EBIT
43,875.000
46,214.000
43,677.000
17,726.000
EBITDA
43,875.000
58,616.000
55,962.000
28,188.000
Reconciled Cost of Revenue
143,687.000
152,254.000
127,433.000
71,794.000
Reconciled Depreciation
9,725.000
12,402.000
12,285.000
10,462.000
Net Income from Continuing Operation Net Minority Interest
38,448.000
40,170.000
31,245.000
13,344.000
Total Unusual Items Excluding Goodwill
--
--
492.000
339.000
Total Unusual Items
--
--
492.000
339.000
Normalized EBITDA
43,875.000
58,616.000
55,470.000
27,849.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
--
--
108.053
40.325
12/31/2020 - 9/19/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers